Earnings History Data for Annexon, Inc. (ANNX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Annexon, Inc.
Annexon Inc. is a clinical-stage biopharmaceutical company. It engages in developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company's product candidate includes ANX005 and ANX007, which are in clinical stage. Annexon Inc. is based in SAN FRANCISCO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13-11-2023 | PM | ANNX | Annexon | 110.00 | -0.43 | -0.50 | 0.00 | Annexon GAAP EPS of -$0.43 beats by $0.07 [11/13/2023 6:39 AM] |
2.27 | 0.14 (6.59%) |
0.0 | 0.0 (0.00%) |
1.57 - 7.65 | 167,001 | 290,000 | 0 | ||
| 07-08-2023 | PM | ANNX | Annexon | 186.00 | -0.47 | -0.54 | 0.00 | Annexon Biosciences GAAP EPS of -$0.47 beats by $0.07 [8/7/2023 6:50 AM] |
3.45 | 0.07 (2.07%) |
3.40 | 0.02 (0.59%) |
2.07 - 7.65 | 355,039 | 620,000 | 231 | ||
| 06-03-2023 | PM | ANNX | Annexon | 241.00 | -0.48 | -0.52 | 0.00 | Annexon Biosciences GAAP EPS of -$0.48 beats by $0.05 [3/6/2023 6:46 AM] |
4.42 | -0.31 (-6.55%) |
4.68 | -0.05 (-1.06%) |
2.06 - 7.65 | 492,690 | 670,000 | 747 | ||
| 03-11-2022 | PM | ANNX | Annexon | 225.00 | -0.51 | -0.87 | 0.00 | Annexon Biosciences GAAP EPS of -$0.51 beats by $0.35 [11/3/2022 9:23 AM] |
4.67 | 0.04 (0.86%) |
0.0 | 0.0 (0.00%) |
2.06 - 18.06 | 36,850 | 130,000 | 0 | ||
| 08-08-2022 | AH | ANNX | Annexon | 194.00 | -0.96 | -0.94 | 0.00 | Annexon Biosciences GAAP EPS of -$0.96 misses by $0.02 [8/8/2022 5:24 PM] |
5.40 | 0.17 (3.25%) |
5.28 | 0.05 (0.96%) |
2.06 - 23.61 | 287,600 | 170,000 | 1,197 | ||
| 09-05-2022 | AH | ANNX | Annexon | 102.00 | -0.92 | -1.00 | 0.00 | Annexon Biosciences GAAP EPS of -$0.92 beats by $0.08 [5/9/2022 5:27 PM] |
3.22 | 0.62 (23.86%) |
2.60 | 0.0 (0.00%) |
2.06 - 24.85 | 1,343,109 | 610,000 | 2,033 | ||
| 01-03-2022 | AH | 4:00 PM ET (Mar 1) |
ANNX | Annexon | 197.00 | -0.97 | -0.90 | 0.00 | Annexon Biosciences GAAP EPS of -$0.97 misses by $0.05 [3/1/2022 5:05 PM] |
4.61 | -0.12 (-2.54%) |
4.73 | 0.0 (0.00%) |
4.56 - 35.99 | 657,484 | 310,000 | 2,676 | |
|
||||||||||||||||||
| 09-11-2021 | AH | 4:00 PM ET (Nov 9) |
ANNX | Annexon | 595.00 | -0.93 | -0.88 | 0.00 | Annexon Biosciences EPS misses by $0.06 [11/9/2021 5:07 PM] |
16.63 | 0.23 (1.40%) |
16.40 | 0.0 (0.00%) |
14.73 - 38.01 | 130,324 | 220,000 | 15,060 | |
| 16-08-2021 | AH | ANNX | Annexon, Inc. | 755.00 | -0.82 | -0.68 | 0.00 | Annexon Biosciences EPS misses by $0.13 [8/16/2021 4:43 PM] |
18.45 | -0.54 (-2.84%) |
18.99 | 0.0 (0.00%) |
17.27 - 38.01 | 104,278 | 100,000 | 3,109 | ||
| 17-05-2021 | AH | ANNX | Annexon, Inc. | 754.00 | -0.68 | -0.60 | 0.00 | Annexon Biosciences EPS misses by $0.07 [5/17/2021 5:02 PM] |
20.75 | -0.01 (-0.05%) |
20.76 | 0.0 (0.00%) |
15.33 - 38.01 | 151,755 | 200,000 | 4,344 | ||
| 25-03-2021 | PM | Before the open (Mar 25) |
ANNX | Annexon, Inc. | 1,120 | -0.61 | -0.42 | 0.00 | Annexon Biosciences reports Q4 results [3/25/2021 7:24 AM] |
28.99 | -0.93 (-3.11%) |
29.92 | 0.0 (0.00%) |
15.33 - 38.01 | 176,398 | 340,000 | 1,580 | |